Overview

Asthma Clinical Research Network (ACRN) Trial - Macrolides in Asthma (MIA)

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
Asthma can be caused by a variety of factors, including tobacco smoke, allergens, and respiratory airway infections. Many people use inhaled corticosteroid medications to treat their symptoms. These medications, however, are not effective for everyone. Clarithromycin is an antibiotic that may effectively treat asthma in these individuals. This study will evaluate the effectiveness of clarithromycin at controlling asthma symptoms.
Phase:
Phase 3
Details
Lead Sponsor:
Milton S. Hershey Medical Center
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Clarithromycin
Fluticasone
Xhance